16 December 2025
Disclaimer: This is a simplified summary of a public company filing. See full disclaimer here.
CIMG Inc.
CIK: 1527613•2 Annual Reports•Latest: 2025-07-30
10-K / July 30, 2025
Revenue:$1,930,291
Income:-$8,555,388
10-K / June 14, 2024
Revenue:$3,348,831
Income:-$8,749,467
10-K / July 30, 2025
Company Summary – CIMG Inc.
Business Overview
- Type: Public company incorporated in Nevada, listed on Nasdaq under ticker "IMG"
- History: Originally known as NuZee, Inc., changed name and ticker in October 2024
- Focus Transition: From specialty coffee and related technologies to expanding sales of maca-based health and wellness products in Asia
Core Business Activities
- Product Development & Distribution:
- Sourced, marketed, and sold maca-derived dietary supplements, functional foods, and beauty products
- Focuses on high-quality, sustainably sourced maca products
- Product Lines:
- Maca Series: Includes Maca Peptide Coffee, Maca-Noni, Maca Wine, Maca Purified Powder
- These contain maca green purification factors, emphasizing natural and clean composition
- Main Markets: Asia (mainly China and Southeast Asia), with distribution via wholesale channels (grocery stores, convenience stores, vending machines)
- Sales Channels: Both online and offline retail, with plans to expand into retail services and digital marketing
Market & Distribution
- Key Markets: Hong Kong, China, other parts of Asia
- Customers: Primarily wholesale distributors such as grocery stores, convenience stores, and vending machine operators
- Distribution Rights: Exclusive rights to maca products produced by Jiangsu Kangduoyuan Beverage Co., Ltd.
Employees & Operations
- Employees (as of September 30, 2024):
- United States: 1 employee
- Hong Kong: 4 employees
- Mainland China: 12 employees
- Total: 17 full-time employees
- Office Locations:
- Hong Kong: Room R2, FTY D, Kin Ga Industrial Building, Tuen Mun
- U.S.: Florida (Delray Beach)
- China: Beijing, with leased facilities expiring in December 2025
Financial Highlights
- 2024 Revenue: ~$1.93 million
- 2023 Revenue: ~$1.76 million
- Change in Revenue: +9.80% (year-over-year)
- Gross Margin (2024): 1.69% (improved from -10.71% in 2023)
- Cost of Sales (2024): ~$1.90 million
- Net Loss (2024): ~$8.97 million (slight increase from ~$8.75 million in 2023)
- Assets & Capital:
- Cash (as of September 30, 2024): ~$460,000
- Stockholders’ equity (as of latest filings): Below Nasdaq minimum requirement (exact amount not specified)
- Outstanding Shares (as of July 2, 2025): 36,397,418 shares
Notable Developments & Strategy
- 2024 Focus:
- Launch of health-oriented maca product series
- Moving away from contract coffee packaging to focus on maca products
- Distribution Rights:
- Exclusive rights to maca products in Asia from Jiangsu Kangduoyuan Beverage Co., Ltd.
- Growth Plans:
- Expand product offerings
- Catalyze geographic expansion, especially in Asia and potentially into North America and Europe
- Strengthen brand awareness through digital marketing
- Increase distribution channels, including retail and online platforms
Risks & Regulatory
- Operations in China subject to extensive regulatory environment and risks related to data security, cybersecurity reviews, and government approvals
- Company has experienced Nasdaq listing deficiencies due to low stock price and insufficient stockholders' equity
- No dividends paid or planned; profits/revenue are reinvested for growth
Summary:
CIMG Inc. is transitioning from a coffee focus to a major player in maca-based health and wellness products, with exclusive distribution rights in Asia, a small but growing revenue base (~$1.93 million in 2024), and approximately 17 full-time employees. It operates offices in Hong Kong, China, and the U.S. and seeks growth via product expansion, geographic reach, and enhanced branding.
